Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis.
Saved in:
| Title: | Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis. |
|---|---|
| Authors: | Nagel, Ines D.1,2 (AUTHOR), Tran, Melanie D.1,3 (AUTHOR), Zhang, Haochen4 (AUTHOR), Cheng, Lingyun1,2 (AUTHOR), Heinke, Anna1,2 (AUTHOR), Mehta, Nehal N.1,2 (AUTHOR), Bartsch, Dirk-Uwe1,2 (AUTHOR), Kalaw, Fritz G. P.1,2,4 (AUTHOR), Morsy, Mohamed1,2 (AUTHOR), Mueller, Arthur J.5 (AUTHOR), Freeman, William R.1,2 (AUTHOR) wrfreeman@health.ucsd.edu |
| Source: | Scientific Reports. 9/30/2025, Vol. 15 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-025-09910-2 |